Details for Patent: 8,536,206
✉ Email this page to a colleague
Summary for Patent: 8,536,206
| Title: | Process for the preparation of roflumilast |
| Abstract: | The invention relates to novel processes for the preparation of high-purity roflumilast. |
| Inventor(s): | Bernhard Kohl, Bernd Mueller, Walter Palosch |
| Assignee: | Nycomed Asset Management GmbH , Nycomed Germany Holding GmbH , AstraZeneca AB |
| Application Number: | US13/547,945 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,536,206 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 8,536,206
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,536,206
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 03005245 | Mar 08, 2003 | |
International Family Members for US Patent 8,536,206
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1606261 | ⤷ Start Trial | PA2010010 | Lithuania | ⤷ Start Trial |
| European Patent Office | 1606261 | ⤷ Start Trial | C20100008 00033 | Estonia | ⤷ Start Trial |
| European Patent Office | 1606261 | ⤷ Start Trial | PA2010010,C1606261 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
